» Articles » PMID: 29147403

Bacterial Spectrum, Isolation Sites and Susceptibility Patterns of Pathogens in Adult Febrile Neutropenic Cancer Patients at a Specialist Hospital in Saudi Arabia

Overview
Journal World J Oncol
Specialty Oncology
Date 2017 Nov 18
PMID 29147403
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Knowing local spectrum and sensitivity for bacterial isolates causing febrile neutropenia is important as starting an appropriate empirical antibiotic therapy is considered a medical emergency in these high-risk patients.

Methods: A retrospective study of a total of 106 microbiologically febrile episodes in hospitalized adult neutropenic cancer patients, who were admitted from May 2009 to May 2013, at King Fahad Specialist Hospital, Dammam, Saudi Arabia, was conducted.

Results: Among 106 microbiologically documented febrile neutropenic episodes, the majority of malignancies were solid tumors accounting for 53.8% (57/106) and hematological malignancies accounted for 46.23% (49/106). The most common malignancies were non-Hodgkin's lymphoma 19.81% (21/106) followed by acute myeloid leukemia 15.09% (16/106), then colorectal cancer 13.21% (14/106), pancreatic cancer and acute lymphoblastic leukemia accounting for 5.66% (6/106) each, multiple myeloma 4.72% (5/106), gall bladder cancer 3.77% (4/106), and lung cancer 2.83% (3/106). A total of 138 bacterial isolates were identified. The overall prevalence of gram-negative bacteria was 65.94% (91/138) and for gram-positive bacteria was 34.06% (47/138). The most common bacterial isolation sites were blood 33.32% (46 isolates), urine 29.71% (41 isolates), wound 19.55% (27 isolates), body fluids 9.41% (13 isolates) and sputum 7.96% (11 isolates). The most predominant pathogens were 30.43 (42/138), 14.49% (20/138), 13.04% (18/138), spp. 7.25% (10/138), spp. 7.25% (10/138), spp. 5.80% (8/138), spp. 4.35% (6/138), spp. 3.62% (5/138), spp. 3.62% (5/138), spp. 2.90% (4/138), 2.17% (3/138), 1.45% (2). and contributed to 0.72% with one isolate each. For gram-negative and , the extended-spectrum beta-lactamases producers (ESBLs) rates were 38% and 22.22% respectively. For Pseudomonas aerugenosa imipenem-cilastatin resistance rate was 18.84%. For gram-positive bacteria, methicillin-resistant (MRSA) rate was 28.62%. The vancomycin-resistant (VRE) rate was 1.18%.

Conclusion: Gram-negative bacteria were more prevalent as a cause of infection in adult cancer patients with febrile neutropenia at our institution, with and with high ESBLs rates being the most common pathogens. Blood stream infections followed by urinary tract infections were the most common sites of infection. The use of initial antibiotic therapy in febrile neutropenic episodes should be based on local bacterial spectrum and susceptibility/sensitivity patterns to prevent treatment failure with increased morbidity and mortality.

Citing Articles

Antibiotic susceptibility and virulence factors of bacterial species among cancer patients.

El-Sherbiny G, Farghal E, Lila M, Shetaia Y, Mohamed S, Elswify M Biotechnol Notes. 2024; 5:27-32.

PMID: 39416689 PMC: 11446349. DOI: 10.1016/j.biotno.2024.02.002.


Urinary Tract Infections in the Kingdom of Saudi Arabia, a Review.

Sula I, Alreshidi M, Alnasr N, Hassaneen A, Saquib N Microorganisms. 2023; 11(4).

PMID: 37110375 PMC: 10145783. DOI: 10.3390/microorganisms11040952.


The Gram-Negative Bacilli Isolated from Caves- and and a Review of Their Involvement in Human Infections.

Ionescu M, Neagoe D, Craciun A, Moldovan O Int J Environ Res Public Health. 2022; 19(4).

PMID: 35206510 PMC: 8872274. DOI: 10.3390/ijerph19042324.


Appropriateness of the Empirical Antibiotics Prescribed and Their Concordance with National Guidelines for Three Selected Infections among Cancer Patients in a Tertiary Care Centre in Sri Lanka.

Chathuranga G, Dissanayake T, Fernando N, Wanigatunge C Int J Microbiol. 2021; 2021:7572215.

PMID: 34621317 PMC: 8492258. DOI: 10.1155/2021/7572215.


Patterns of Bacterial Isolates and their Resistance to Antibiotics in Patients with Chemotherapy-induced Febrile Neutropenia at a University Hospital.

Al Saifi S, Al Adawi B, Burney I Oman Med J. 2021; 36(4):e290.

PMID: 34497720 PMC: 8406491. DOI: 10.5001/omj.2021.87.


References
1.
Swati M, Gita N, Sujata B, Jijina Farah , Preeti M . Microbial etiology of febrile neutropenia. Indian J Hematol Blood Transfus. 2011; 26(2):49-55. PMC: 3002059. DOI: 10.1007/s12288-010-0029-z. View

2.
Freifeld A, Bow E, Sepkowitz K, Boeckh M, Ito J, Mullen C . Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis. 2011; 52(4):e56-93. DOI: 10.1093/cid/cir073. View

3.
Hughes W, Armstrong D, Bodey G, Bow E, Brown A, Calandra T . 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis. 2002; 34(6):730-51. DOI: 10.1086/339215. View

4.
Alp S, Akova M . Management of febrile neutropenia in the era of bacterial resistance. Ther Adv Infect Dis. 2014; 1(1):37-43. PMC: 4040719. DOI: 10.1177/2049936113475610. View

5.
Viscoli C, Varnier O, Machetti M . Infections in patients with febrile neutropenia: epidemiology, microbiology, and risk stratification. Clin Infect Dis. 2005; 40 Suppl 4:S240-5. DOI: 10.1086/427329. View